[1]
H. TEAIMA, M. et al. 2022. NIOSOMES VERSUS PRONIOSOMES AS PROMISING DRUG DELIVERY SYSTEMS IN TREATMENT OF DIABETES MELLITUS. International Journal of Applied Pharmaceutics. 14, 5 (Sep. 2022), 32–40. DOI:https://doi.org/10.22159/ijap.2022v14i5.44039.